Salatan, Janese A.
HRN: 23-13-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2023
CEFUROXIME 1.5GM (VIAL)
06/28/2023
07/05/2023
IV
1.5 Grams
Q8
SP LT CS W IUD Insertion
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes